— Know what they know.
/
Not Investment Advice

MTD

NYSE · USD
Mettler-Toledo International Inc.
Healthcare · Medical - Diagnostics & Research
CEO Patrick K. Kaltenbach Employees 16,600 R&D / revenue 5.0%
Last price
$1,622.29−1.02%last session
Market cap
$32.5B
P/E (TTM)
36.4x
From 52w high
−2.3%
From 52w low
+58.6%
1-year return
+19.2%
RSI 14 · vs SMA200
71.0 · +22.3%
IS score
62.7/ 100
Factor model across 8 sub-scores, ranked against 3,010 US stocks. Describes the business, not the outlook.
Download full factsheet (PDF)

One year, rebased to 100

MTD   SPY   XLV (sector ETF) · weekly closes
8090100110120Jan 26Apr 26Jul 26Oct 26XLV 124MTD 119SPY 116

Score DNA

Each bar is a 0-100 score within the scored universe
75
Profitability
62
Growth
35
Value
74
Momentum
100
Risk (safety)
62
Quality
42
Balance sheet
74
Earnings quality

Flags

Strengths
✓ Piotroski 8+✓ Congress buying
Warnings
None of the computed warning flags fires for MTD (Altman, Beneish, accruals, FCF, dilution).
Observations
Moat model: Weak, Cost AdvantagePiotroski 8 / 9Altman Z 10.1Beta 1.222 of 4 smart-money sources active

Smart-money strip

Each disclosure source on its own window. Filings coinciding is not coordination.
INSForm 4 · 180 days
Insider open-market buys
0
5 open-market sales, $6.1M
Form 144 notices (12m): 4, $3.0M proposed, not confirmed sales
CONGSTOCK Act · 180 days
Congressional purchases
1
Last disclosed purchase 2026-09-11
Members disclose in ranges, 30-45 days after the trade
13F13F · quarter to 2026-06-30
Net change in institutional holders
−15
81 new holders, 88 closed
811 filers hold 102.8% · 250 added, 333 trimmed
ETFETF holdings · 30 days
Net funds accumulating
−9
946 funds adding shares
955 funds trimming · counts of funds, not dollars
DARKFINRA · daily
Short-sale share of off-exchange volume
63.7%
20-day avg 50.7%, 50-day avg 45.5%
Latest 13.0 pp over its 20-day average · a flow, not short interest

Key financials · FY2025

USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.
Income statement
Revenue$4.0B
Revenue growth YoY+4.0%
Gross margin57.5%
Operating income$1.1B
Operating margin27.8%
Net income$869.2M
Net margin21.6%
EPS (diluted)$42.17
Cash flow
Operating cash flow$955.8M
Capital expenditure$107.1M
Free cash flow$848.6M
FCF conversion (FCF / OCF)88.8%
Stock-based compensation$22.5M
FCF less SBC$826.1M
Buybacks$800.0M
Dividends$0
Balance sheet & returns
Cash & short-term investments$66.9M
Total debt$2.3B
Net debt$2.2B
Shareholders' equity−$23.6M
Goodwill & intangibles$1.0B
Debt / equity164.70
ROE (TTM)-1,199.9%
ROIC (TTM)38.2%
Operating margin by fiscal year
26.8%FY202128.7%FY202228.5%FY202329.1%FY202427.8%FY2025
Revenue $3.7B (FY2021) to $4.0B (FY2025), a 2.0% CAGR.

Valuation

P/E (TTM)36.4x
EV / EBITDA26.5x
Price / sales7.86x
Price / FCF37.6x
FCF yield2.66%
Buyback yield2.46%
SBC / revenue0.6%
Price / book2,545.66x
Forward P/E FY202634.3x
Forward P/E FY202731.4x
Forward P/E FY202828.4x
Forward multiples divide today's price by Street EPS estimates. Street mean target $1,570.71 across 7 analysts last quarter is theirs, not ours.

MTD vs industry median

126 companies in Medical - Diagnostics & Research
Gross margin 58.4% 48.5% Operating margin 28.4% -9.4% Net margin 21.9% -9.5% ROIC 38.2% -2.5%
MTD (TTM)Industry median Asset turnover 1.13 vs industry 0.54 · financial leverage 286.28

Earnings delivery

Next report 2026-11-05 · consensus EPS $12.12
92%
beat rate, 11 of 12 quarters
+4.5%
median EPS surprise
10
longest beat streak
+1-7+16+7+2+6+4+5+5+4+2+6
EPS surprise in % vs the consensus at the time, oldest (left) to newest, 2023-11-09 to 2026-07-30. Bars cap at ±60%.

Peers

Market-cap band, not the industry cohort above
CompanyMkt capP/EROENet marginRev growth12m return
MTD Mettler-Toledo International $32.5B36.4x-1,199.9%21.9%+4.0% +19.2%
ILMN Illumina, Inc. $39.6B48.5x32.4%17.9%+4.9% +173.7%
DGX Quest Diagnostics Incorporat $25.9B24.6x14.4%10.5%+9.9% +25.8%
LH Labcorp Holdings Inc. $25.8B26.1x11.7%8.0%+6.4% +13.2%
WAT Waters Corporation $42.9B108.7x1.9%-8.3%+52.5% +30.5%
IQV IQVIA Holdings Inc. $43.9B32.8x23.0%5.9%+8.2% —
IDXX IDEXX Laboratories, Inc. $44.1B39.4x74.2%27.8%+12.8% —
A Agilent Technologies, Inc. $48.8B34.0x21.0%19.3%+8.6% —
12-month window: SPY +15.9%, sector ETF XLV +24.2%. Past returns describe history only.

Recent 8-K filings

2026-08-03Officer/Director Change; Regulation FD; Exhibits
2026-07-30Earnings Release; Exhibits
2026-05-13Officer/Director Change
2026-05-07Earnings Release; Exhibits
2026-02-05Results of Operations and Financial Condition; Financial Statements and Exhibits
2026-01-20Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statements and Exhibits

Context

Shares outstanding20,036,600
Free float99.5%
Institutional ownership102.8%
Beta1.22
Dividend yield0.00%
Last dividendNone on file
50 / 200-day average$1,439.60 / $1,325.85
Large-cap Healthcare median P/E29.7x

Full factsheet

The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Weak).

Read it in the browser Download (PDF)

All fundamentals · 140 measures in 13 categories

Percentile = where MTD sits among 30 scored companies in Medical - Diagnostics & Research (0 = lowest value, 100 = highest). It is a position, not a grade.
ValuationProfitability (TTM)Returns on capitalGrowthMargin history & stabilityLiquidity (latest quarter)Leverage & solvency (latest quarter)EfficiencyCash flow & earnings qualityDividends & buybacksScores & forensic checksPer shareSize (TTM)

Valuation

MeasureMTDIndustry medianIndustry percentileSector median
P/E (TTM) 35.9x 35.5x
53rd		 27.6x
PEG (P/E ÷ 3-yr EPS CAGR) 9.66 2.73
100th		 1.28
Price / sales 7.9x 5.7x
72nd		 3.7x
Price / book —
Price / tangible book —
Price / free cash flow 37.6x 34.4x
63rd		 21.2x
Price / operating cash flow 33.3x 26.0x
70th		 17.1x
Enterprise value $34.6B $16.3B
72nd		 $2.5B
EV / sales 8.4x 5.9x
72nd		 3.8x
EV / EBITDA 26.5x 25.4x
62nd		 16.2x
EV / EBIT 29.5x 29.2x
53rd		 23.0x
EV / free cash flow 40.0x 35.1x
63rd		 24.6x
Earnings yield 2.8% 1.7%
69th		 -0.3%
FCF yield 2.7% 2.5%
59th		 1.7%
Operating cash flow yield 3.0% 3.2%
45th		 2.9%
Graham number (per share) $25.35 $65.89
24th		 $26.70

Profitability (TTM)

MeasureMTDIndustry medianIndustry percentileSector median
Gross margin 58.4% 52.9%
59th		 65.1%
EBITDA margin 31.5% 15.0%
90th		 6.6%
Operating margin 28.4% 11.0%
93rd		 3.5%
EBIT margin 28.4% 9.1%
93rd		 2.4%
Net margin 21.9% 7.5%
93rd		 0.3%
NOPAT margin 23.4% 9.5%
97th		 2.7%
FCF margin 20.9% 9.2%
83rd		 4.3%
Operating cash flow margin 23.6% 15.0%
76th		 7.1%
R&D / revenue 5.0% 7.2%
34th		 12.4%
SG&A / revenue 24.9% 29.8%
38th		 37.9%
Stock comp / revenue 0.6% 1.8%
7th		 4.5%
Effective tax rate 17.5% 20.5%
31st		 21.0%

Returns on capital

MeasureMTDIndustry medianIndustry percentileSector median
ROE (on average equity) —
ROA 25.6% 3.2%
93rd		 -0.3%
ROIC 46.7% 5.6%
97th		 5.5%
ROCE 47.5% 4.0%
93rd		 2.3%
Return on tangible assets 33.2% 3.5%
97th		 1.7%
Cash ROIC (OCF / invested capital) 47.0% 11.8%
90th		 9.7%
Gross profitability (GP / assets) 65.7% 22.3%
90th		 29.9%
ROIC, 3-yr average 42.7% 3.7%
100th		 2.6%
ROIC, 5-yr average —
ROE, 5-yr average —
Incremental ROIC 142.4% -3.0%
85th		 17.2%

Growth

MeasureMTDIndustry medianIndustry percentileSector median
Revenue growth (TTM YoY) 6.9% 8.1%
43rd		 10.5%
Revenue growth (QoQ) 8.5% 8.1%
59th		 7.2%
Revenue CAGR, 3 yr 1.5% 4.9%
26th		 10.7%
Revenue CAGR, 5 yr 3.5% 7.0%
33rd		 12.1%
Gross profit CAGR, 3 yr 1.9% 5.3%
30th		 10.6%
Operating income CAGR, 3 yr 0.1% 6.4%
33rd		 11.7%
Net income growth (TTM YoY) 9.1% 11.8%
31st		 17.5%
Net income CAGR, 3 yr 0.6% 6.7%
33rd		 11.3%
EPS growth (TTM YoY) 12.5% 15.1%
31st		 19.2%
EPS CAGR, 3 yr 3.7% 9.3%
33rd		 14.0%
EPS CAGR, 5 yr 8.2% -1.0%
64th		 8.1%
FCF growth (TTM YoY) 1.9% 12.4%
44th		 18.6%
FCF CAGR, 3 yr 0.2% 7.7%
7th		 15.4%
Operating cash flow CAGR, 3 yr 0.2% 8.0%
24th		 11.9%
Book value CAGR, 3 yr —
Dividend CAGR, 3 yr —
Sustainable growth rate —

Margin history & stability

MeasureMTDIndustry medianIndustry percentileSector median
Gross margin, 3-yr average 57.9% 53.7%
64th		 62.6%
Operating margin, 3-yr average 28.3% 8.7%
93rd		 1.0%
Net margin, 3-yr average 21.4% 4.1%
96th		 -2.6%
FCF margin, 3-yr average 22.3% 10.5%
93rd		 3.2%
Revenue stability (0-1) 0.71 0.82
39th		 0.80
Earnings stability (0-1) 0.46 0.46
50th		 0.37
Margin stability (0-1) 0.99 0.93
100th		 0.93

Liquidity (latest quarter)

MeasureMTDIndustry medianIndustry percentileSector median
Cash & short-term investments $51.4M $520.8M
0th		 $330.9M
Net cash (− = net debt) −$2.1B −$874.6M
34th		 $8.4M
Working capital $146.9M $404.8M
10th		 $381.1M
Current ratio 1.12 2.13
10th		 3.02
Quick ratio 0.78 1.77
7th		 2.51
Cash ratio (cash + ST investments / current liabilities) 0.04 0.96
0th		 1.43
Defensive interval (days) 231 days 466 days
7th		 415 days

Leverage & solvency (latest quarter)

MeasureMTDIndustry medianIndustry percentileSector median
Total debt $2.1B $1.7B
55th		 $289.1M
Debt / equity —
Net debt / equity —
Debt / assets 57.5% 28.5%
93rd		 24.4%
Debt / capital 99.4% 33.6%
100th		 31.1%
Debt / EBITDA 1.62 3.30
19th		 2.62
Net debt / EBITDA 1.58 2.39
38th		 1.42
Interest coverage (EBIT / interest) 16.9x 2.9x
88th		 2.1x
Cash interest coverage 14.1x 6.7x
72nd		 3.6x
Debt payback (years of OCF) 2.2 yrs 3.8 yrs
30th		 2.7 yrs
Liabilities / assets 99.7% 45.2%
97th		 49.8%
IS credit model rating AA — —
Implied credit spread (bps) 80 175
14th		 225

Efficiency

MeasureMTDIndustry medianIndustry percentileSector median
Asset turnover 1.17 0.56
86th		 0.56
Fixed asset turnover 4.97 4.31
66th		 4.87
Inventory turnover 4.3 7.2
28th		 2.7
Receivables turnover 5.9 6.5
34th		 6.4
Days sales outstanding 62 days 56 days
66th		 57 days
Days inventory outstanding 85 days 51 days
72nd		 136 days
Days payables outstanding 47 days 45 days
55th		 59 days
Cash conversion cycle (days) 100 days 67 days
69th		 70 days
Capex / revenue 2.7% 3.4%
34th		 2.6%
Capex / depreciation 0.85 0.69
69th		 0.55
Operating expense ratio 30.8% 45.1%
34th		 56.5%

Cash flow & earnings quality

MeasureMTDIndustry medianIndustry percentileSector median
Operating cash flow / net income 1.08 1.58
6th		 1.61
FCF / net income 0.95 1.14
18th		 1.36
FCF / operating cash flow 88.6% 76.8%
70th		 81.2%
Capex / operating cash flow 11.4% 23.2%
30th		 18.8%
Accruals ratio -2.0% -4.3%
79th		 -5.4%
Sloan accruals ratio -3.4% -1.5%
31st		 -1.3%
Earnings quality score (0-1) 1.00 1.00
24th		 0.75

Dividends & buybacks

MeasureMTDIndustry medianIndustry percentileSector median
Dividend yield 0.0% 0.0%
0th		 0.0%
Dividend per share (TTM) $0.00 $0.00
0th		 $0.00
Payout ratio (dividends / net income) 0.0% 0.0%
0th		 0.0%
Dividends / FCF 0.0% 0.0%
0th		 0.0%
Dividend growth (YoY) —
Buyback yield 2.4% 0.9%
76th		 0.0%
Shareholder yield (dividends + buybacks) 2.4% 1.1%
69th		 0.0%
Share count change (YoY) -2.9% -0.7%
18th		 2.0%
Buybacks, last 5 years $3.4B $129.7M
83rd		 $0

Scores & forensic checks

MeasureMTDIndustry medianIndustry percentileSector median
IS score 63 50
72nd		 46
IS profitability 75 36
90th		 22
IS growth 62 55
64th		 60
IS value 35 40
38th		 39
IS momentum 74 72
54th		 67
IS risk (safety) 100 80
62nd		 80
IS quality 62 62
48th		 49
IS balance sheet 42 51
38th		 55
IS earnings quality 74 69
69th		 56
IS cash flow 63 50
62nd		 41
Piotroski F-score (0-9) 8 6
76th		 5
Altman Z-score 10.1 3.4
86th		 3.2
Beneish M-score −2.51 −2.60
82nd		 −2.62
Ohlson O-score −5.36 −8.12
93rd		 −7.16
IS credit score 86 67
79th		 62

Per share

MeasureMTDIndustry medianIndustry percentileSector median
EPS, diluted (TTM) $44.91 $1.54
100th		 −$0.03
Book value per share $0.64 $17.72
3rd		 $7.10
Tangible book per share −$49.13 $0.32
7th		 $1.91
Revenue per share $204.99 $26.05
100th		 $9.38
FCF per share $42.84 $2.08
100th		 $0.46
Operating cash flow per share $48.36 $3.59
100th		 $0.93
Cash per share $2.55 $6.18
21st		 $3.51

Size (TTM)

MeasureMTDIndustry medianIndustry percentileSector median
Market cap $32.5B $13.8B
72nd		 $2.4B
Revenue $4.1B $2.5B
66th		 $770.2M
EBITDA $1.3B $438.4M
72nd		 $56.1M
Net income $905.6M $139.0M
76th		 −$3.3M
Free cash flow $864.0M $268.0M
69th		 $41.2M
Total assets $3.7B $3.4B
55th		 $1.3B
Shareholders' equity $12.8M $1.5B
3rd		 $568.4M
Employees 16,600 6,319
72nd		 1,086

Insider transactions, last 6 months

Form 4 · most recent 12
DateInsiderTypeSharesPriceValueOwned after
2026-08-28Shuman-Fabbri Natalia
Director
 Award / grant 16——16
2026-08-27Kaltenbach Patrick
President and CEO
 Option exercise 942$1,024.55$965,1265,422
2026-08-27Kaltenbach Patrick
President and CEO
 Open-market sale 942$1,425.00$1.3M4,480
2026-08-27Kaltenbach Patrick
President and CEO
 Option exercise 942$1,024.55$965,1264,413
2026-08-05Salice Thomas P
Director
 Option exercise 417$397.95$165,945709
2026-08-05Salice Thomas P
Director
 Open-market sale 417$1,440.41$600,651292
2026-08-05Salice Thomas P
Director
 Option exercise 417$397.95$165,9450
2026-08-03Keller Gerry
Head of Process Analytics
 Option exercise 240$720.81$172,994499
2026-08-03Keller Gerry
Head of Process Analytics
 Open-market sale 240$1,427.14$342,514259
2026-08-03Keller Gerry
Head of Process Analytics
 Option exercise 240$720.81$172,994235
2026-08-03Vadala Shawn
Chief Financial Officer
 Option exercise 2,240$595.31$1.3M7,819
2026-08-03Vadala Shawn
Chief Financial Officer
 Open-market sale 2,240$1,432.00$3.2M5,579

Shares acquired vs disposed, by month

acquired disposed · all Form 4 types
MayAug

By transaction type, 6 months

TypeDirectionFilingsSharesValue
Award / grantAcquired135,098$3.9M
Open-market saleDisposed54,254$6.1M
Option exerciseDisposed54,254$2.8M
Option exerciseAcquired54,254$2.8M
—Disposed10—
Awards, option exercises and tax withholding are compensation mechanics; open-market buys and sales are the discretionary ones.

Form 144 notices

12 months: 4 notices · 2,138 shares · $3.0M
FiledFilerShares proposedEst. proceeds
2026-08-05Thomas Salice417$600,651
2026-08-03Thomas Salice415$599,516
2026-07-28Michael Kelly832$1.2M
2025-11-10Elisha Finney474$679,512
A Form 144 is notice of a proposed sale, not a confirmed one.

Congress trades

12 months: House 4 trades (1 purchases) · Senate 0 (0 purchases)
TradedMemberChamberTypeAmountDisclosed
2026-09-11Ro KhannaHousePurchase$1,001 - $15,0002026-10-09
2026-01-29Ro KhannaHouseSale$1,001 - $15,0002026-02-10
2025-12-08Julia LetlowHouseSale (Full)$1,001 - $15,0002026-01-13
2025-12-07Julia LetlowHouseSale (Full)$1,001 - $15,0002026-01-13
2023-04-03Tommy TubervilleSenateSale (Full)$1,001 - $15,0002023-05-12
2023-04-03Tommy TubervilleSenateSale (Full)$1,001 - $15,0002023-05-11
2023-04-03Tommy TubervilleSenateSale (Full)$1,001 - $15,0002023-05-11
2023-04-03Thomas Hawley TubervilleSenateSale (Full)$1,001 - $15,0002023-05-11
STOCK Act disclosures, in ranges, filed up to 45 days after the trade.

Largest 13F holders

Quarter to 2026-06-30, the latest most managers have filed
ManagerSharesValue% of shares out
BlackRock, Inc.1,882,344$2.4B9.39%
Capital International Investors1,521,543$1.9B7.59%
VANGUARD CAPITAL MANAGEMENT LLC1,319,636$1.7B6.59%
VANGUARD PORTFOLIO MANAGEMENT LLC1,010,490$1.3B5.04%
STATE STREET CORP951,679$1.2B4.75%
T. Rowe Price Investment Management, Inc.694,424$887.1M3.47%
GEODE CAPITAL MANAGEMENT, LLC612,153$780.5M3.06%
Bank of New York Mellon Corp595,348$760.6M2.97%
WELLINGTON MANAGEMENT GROUP LLP459,064$586.5M2.29%
NORGES BANK399,539$510.4M1.99%
PineStone Asset Management Inc.326,120$416.6M1.63%
PRICE T ROWE ASSOCIATES INC /MD/315,332$402.8M1.57%
Fiera Capital Corp295,190$377.1M1.47%
MORGAN STANLEY273,808$349.8M1.37%
GOLDMAN SACHS GROUP INC252,137$322.1M1.26%

Institutional ownership by quarter

2023-092026-06102.8%
% of shares held by 13F filers
2023-092026-06811
Number of 13F filers holding

Holder changes by quarter

QuarterHoldersOwnershipNewIncreasedReducedClosed
2026-06-30811102.8%8125033388
2026-03-3182698.7%8727727897
2025-12-31854100.8%12926927456
2025-09-30802101.3%8526526563
2025-06-30790103.9%8327928797
2025-03-31814100.5%7527231263
2024-12-3181598.6%10529226773
2024-09-3079297.1%6426429160
2024-06-3079598.0%8824231969
2024-03-31787100.3%8224630653
2023-12-31767101.3%11722232277
2023-09-30738102.5%6627427579

Schedule 13D / 13G filers

FiledFormFiler% of classShares
2026-08-12SCHEDULE 13G/ACapital International Investors7.9%1,595,726
2026-07-31SCHEDULE 13GVanguard Portfolio Management5.0%1,012,777
2026-04-30SCHEDULE 13GVanguard Capital Management7.5%1,525,553
2026-03-27SCHEDULE 13G/AThe Vanguard Group0.0%0
Required above 5% of a class; 13G is the passive form.

ETFs with the largest holding

ETFWeight in fundHolding value
VITSX0.04%$960.5M
VSMPX0.04%$960.5M
VTSAX0.04%$960.5M
VTI0.04%$960.5M
VFFSX0.05%$796.8M
VOO0.05%$796.8M

Share structure

Shares outstanding20,036,600
Float19,926,959
Free float99.5%

Income statement

Fiscal years, USD
FY2021FY2022FY2023FY2024FY2025
Revenue$3.7B$3.9B$3.8B$3.9B$4.0B
Cost of revenue$1.6B$1.7B$1.6B$1.6B$1.7B
Gross profit$2.1B$2.2B$2.2B$2.3B$2.3B
R&D$169.8M$177.1M$185.3M$189.4M$199.4M
SG&A$944.0M$938.5M$904.1M$936.3M$998.3M
Operating income$994.7M$1.1B$1.1B$1.1B$1.1B
EBITDA$1.1B$1.2B$1.2B$1.2B$1.2B
Pretax income$949.4M$1.1B$973.7M$1.0B$1.0B
Income tax$180.4M$198.1M$184.9M$174.1M$179.7M
Net income$769.0M$872.5M$788.8M$863.1M$869.2M
EPS, diluted$32.78$38.41$35.90$40.67$42.17
Diluted shares23.5M22.7M22.0M21.3M20.6M

Balance sheet

FY2021FY2022FY2023FY2024FY2025
Cash & short-term investments$98.6M$96.0M$69.8M$59.4M$66.9M
Receivables$647.3M$709.3M$663.9M$687.1M$778.2M
Inventory$414.5M$441.7M$385.9M$342.3M$387.2M
Total current assets$1.3B$1.4B$1.2B$1.2B$1.4B
PP&E, net$799.4M$778.6M$803.4M$770.3M$845.6M
Goodwill & intangibles$956.1M$966.2M$955.5M$926.1M$1.0B
Total assets$3.3B$3.5B$3.4B$3.2B$3.7B
Accounts payable$272.9M$252.5M$210.4M$215.8M$266.6M
Total current liabilities$1.1B$1.1B$1.2B$1.2B$1.2B
Long-term debt$1.6B$1.9B$1.9B$1.8B$2.2B
Total liabilities$3.2B$3.5B$3.5B$3.4B$3.7B
Shareholders' equity$171.4M$24.8M−$149.9M−$126.9M−$23.6M

Cash flow statement

Outflows are negative
FY2021FY2022FY2023FY2024FY2025
Net income$769.0M$872.5M$788.8M$863.1M$869.2M
Depreciation & amortization$108.1M$113.0M$121.2M$123.2M$125.6M
Stock-based compensation$19.6M$19.7M$17.9M$20.0M$22.5M
Change in working capital$4.4M−$172.6M$51.4M−$9.8M−$65.3M
Operating cash flow$908.8M$859.1M$965.9M$968.3M$955.8M
Capital expenditure−$107.6M−$121.2M−$105.3M−$103.9M−$107.1M
Free cash flow$801.2M$737.8M$860.6M$864.4M$848.6M
Investing cash flow−$314.1M−$139.4M−$131.7M−$119.5M−$193.9M
Net debt issued / repaid$392.0M$359.9M$29.8M−$18.7M$21.5M
Buybacks−$1,000.0M−$1.1B−$900.0M−$850.0M−$800.0M
Dividends paid$0$0$0$0$0

Ratio history

Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end
FY2021FY2022FY2023FY2024FY2025
Gross margin56.7%57.2%57.3%58.2%57.5%
Operating margin26.8%28.7%28.5%29.1%27.8%
Net margin20.7%22.3%20.8%22.3%21.6%
FCF margin21.6%18.8%22.7%22.3%21.1%
ROE338.7%889.3%-1,260.6%-623.6%-1,154.9%
ROIC43.0%44.6%44.2%48.2%41.1%
ROA25.0%25.6%23.0%26.2%25.0%
Debt / equity10.5185.94-14.65-16.79-99.14
Interest coverage22.9x20.4x13.7x15.0x16.3x
Current ratio1.111.201.041.021.14
Revenue growth+20.5%+5.4%−3.4%+2.2%+4.0%
EPS growth+31.7%+17.6%−6.6%+12.5%+4.3%
P/E at year end51.2x37.1x33.4x29.9x32.7x
EV / EBITDA at year end37.4x27.7x24.0x22.4x24.7x
FCF yield at year end2.03%2.28%3.27%3.35%2.99%
Dividend payout0.0%0.0%0.0%0.0%0.0%

Revenue by segment

FY2021FY2022FY2023FY2024FY2025
Laboratory products and services$2.1B$2.2B$2.1B$2.2B$2.2B
Industrial products and services$1.4B$1.5B$1.5B$1.5B$1.6B
Retail products and services$188.4M$178.8M$229.1M$196.4M$205.9M

Revenue by region · FY2025

Asia$1.2B · 100%

Street estimates by fiscal year

Next report 2026-11-05 · consensus EPS $12.12 · these are analysts' numbers, not ours
Fiscal yearRevenue (mean)Revenue rangeEPS (mean)EPS rangeAnalystsP/E on mean EPS
2026$4.2B$4.2B – $4.3B$47.34$47.23 – $47.52834.3x
2027$4.4B$4.4B – $4.5B$51.70$51.28 – $51.98831.4x
2028$4.7B$4.6B – $4.7B$57.21$55.83 – $59.28428.4x

Reported vs expected, every quarter on file

ReportedEPS expectedEPS actualEPS surpriseRevenue expectedRevenue actualRevenue surprise
2026-07-30$10.85$11.46+5.6%$1.0B$1.0B−0.0%
2026-05-07$8.71$8.91+2.3%$943.1M$947.1M+0.4%
2026-02-05$12.80$13.36+4.4%$1.1B$1.1B+2.3%
2025-11-06$10.66$11.15+4.6%$997.3M$1.0B+3.3%
2025-07-31$9.60$10.09+5.1%$957.6M$983.2M+2.7%
2025-05-01$7.88$8.19+3.9%$876.6M$883.7M+0.8%
2025-02-06$11.72$12.41+5.9%$1.0B$1.0B+3.6%
2024-11-08$10.01$10.21+2.0%$944.8M$954.5M+1.0%
2024-08-01$9.03$9.65+6.9%$929.1M$946.8M+1.9%
2024-05-09$7.64$8.89+16.4%$879.7M$925.9M+5.3%
2024-02-08$10.10$9.40−6.9%$959.4M$935.0M−2.5%
2023-11-09$9.74$9.80+0.6%$952.0M$942.5M−1.0%
2023-07-27$9.97$10.19+2.2%$1.0B$982.1M−6.0%
2023-05-04$8.60$8.69+1.0%$918.7M$928.7M+1.1%
2023-02-09$11.66$12.10+3.8%$1.0B$1.1B+2.7%
2022-11-03$9.83$10.18+3.6%$972.1M$985.8M+1.4%
2022-07-28$8.76$9.39+7.2%$951.5M$978.4M+2.8%
2022-05-05$7.25$7.87+8.6%$868.5M$897.8M+3.4%
2022-02-10$10.08$10.53+4.5%$1.0B$1.0B+1.6%
2021-11-04$8.24$8.72+5.8%$924.9M$952.0M+2.9%
2021-07-29$7.62$8.10+6.3%$875.3M$924.4M+5.6%
2021-05-06$5.61$6.56+16.9%$757.9M$804.4M+6.1%
2021-02-04$8.72$9.26+6.2%$879.9M$938.0M+6.6%
2020-11-05$5.95$7.02+18.0%$684.3M$807.4M+18.0%

Off-exchange (dark pool) volume, weekly

FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)
0.206-150.706-220.306-290.207-060.207-130.407-200.407-270.308-030.308-100.608-170.308-240.308-31
Week ofNotionalSharesTrades
2026-08-31$327.8M239,31030,795
2026-08-24$259.2M184,50027,518
2026-08-17$627.0M445,43334,942
2026-08-10$289.7M202,78726,747
2026-08-03$344.4M241,17731,518
2026-07-27$439.9M317,49931,123

Short-sale share of off-exchange volume

daily 20-day average
07-2310-1563.7%
DateShort shareShort volumeTotal volume
2026-10-1563.7%84,643132,883
2026-10-1458.4%63,140108,130
2026-10-1361.5%57,15592,996
2026-10-1226.7%31,698118,803
2026-10-0952.6%47,09289,586
2026-10-0845.4%63,890140,701
2026-10-0744.3%43,13397,443
2026-10-0663.9%63,969100,037
2026-10-0562.9%45,49972,287
2026-10-0233.7%17,00950,472
A daily flow measure from FINRA, not short interest.

Seasonality

Average return by calendar month
+1.2Jan-1.4Feb+0.5Mar+2.6Apr+0.7May+0.1Jun+3.4Jul-0.7Aug+0.3Sep+1.6Oct+6.5Nov+0.1Dec
MonthAvg returnUp yearsYears
Jan+1.2%55%20
Feb−1.4%45%20
Mar+0.5%57%21
Apr+2.6%50%20
May+0.7%50%20
Jun+0.1%50%20
Jul+3.4%60%20
Aug−0.7%40%20
Sep+0.3%55%20
Oct+1.6%70%20
Nov+6.5%85%20
Dec+0.1%45%20
History, not a forecast.

Indicators

as of 2026-10-16
RSI 1471.0
MFI59.4
ADX41.0
Stochastic %K / %D87.0 / 89.5
Williams %R-21.0
CCI165
TSI / signal38.0 / 29.6
Chaikin money flow0.16
ATR$40.79
Bollinger width13.1%
Volume vs 20-day avg1.10x
SupertrendUp

Moving averages and bands

level (price vs level)
SMA 20$1,536.15 (+5.6%)
SMA 50$1,443.59 (+12.4%)
SMA 200$1,326.89 (+22.3%)
EMA 21$1,530.03 (+6.0%)
EMA 50$1,457.22 (+11.3%)
EMA 200$1,349.39 (+20.2%)
Bollinger upper$1,636.35 (−0.9%)
Bollinger lower$1,435.94 (+13.0%)
Parabolic SAR$1,514.18 (+7.1%)
Open the live chart, 110+ indicators

About Mettler-Toledo International Inc.

Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances, advanced liquid handling systems (such as pipetting solutions), automated laboratory reactors, titrators, pH meters, sensors and analyzers for process analytics, instruments for evaluating physical properties, thermal analysis systems, and various other analytical tools. These hardware offerings are complemented by LabX, their proprietary software platform designed for managing and analyzing instrument-generated data. For industrial applications, the company offers robust weighing instruments with associated terminals, automated systems for dimensional measurement and data capture, heavy-duty vehicle scales, specialized industrial software, and a full suite of product inspection technologies. This includes metal detectors, X-ray inspection systems, checkweighers, camera-based imaging equipment, and solutions for track-and-trace. Additionally, Mettler-Toledo provides sophisticated retail weighing solutions, encompassing networked scales and accompanying software, standalone scales, and automated packaging and labeling systems specifically tailored for fresh food items. The company caters to a wide spectrum of clients, including the life sciences sector, independent research organizations, testing laboratories, food and beverage manufacturers, food retailers, chemical, specialty chemical, and cosmetics companies, transportation and logistics firms, metals and electronics industries, and the academic community. Sales and support are conducted through both a direct sales force and an established network of indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is headquartered in Columbus, Ohio.

https://www.mt.com

Key executives

NameTitlePayBorn
Patrick K. KaltenbachPresident & Chief Executive Officer$1.8M1963
Susan Graham-BryceChief Human Resources Officer$1.1M1976
Gerhard KellerHead of Process Analytics$810,0041968
Shawn VadalaChief Financial Officer$720,4001969
Richard WongHead of Asia/Pacific$619,9151965
Marc de La GueronniereHead of North American Market Organization, Global Service & Commercial Excellence$525,2071964
Markus KoepfliChief Information Officer——
Oliver WittorfHead of Product Inspection, Retail & Global Supply Chain—1976

Executive pay, latest proxy

ExecutiveYearSalaryStock awardsIncentiveTotal
Patrick Kaltenbach President and Chief Executive Officer2025$1.1M$3.3M$462,984$6.7M
Shawn P. Vadala Chief Financial Officer2025$490,000$1.1M$198,450$2.4M
Susan Graham-Bryce Chief Human Resources Officer2025$396,539$845,324$156,851$2.3M
Marc de La Guéronnière Head of EU and NA2025$312,535$616,380$137,367$1.6M
Richard Wong Head of Asia and Pacific2025$424,542$392,439$161,847$1.2M

Employees

16k201816k201915k202016k202116k202217k202317k202417k2025

Dividends

Ex-dateAmountPaid
None on file.

Moat model

Weak · Cost Advantage · 2026-06-30
Cost advantage76
Intangibles60
Switching costs32
Network effect40
Efficient scale56
Our component scores (0-100) and overall 52.6; a model of the business, not a call on the stock.
InsiderStreet reports findings from filings and market data. Nothing on this page is a recommendation to buy or sell.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms